Advertisement

Topics

Respiratory Therapeutics Group Company Profile

23:24 EST 13th December 2018 | BioPortfolio

RTG is a global manufacturer of Respiratory Devices, with an extensive brand portfolio of respiratory disposable devices, products and service solutions designed by Respiratory Therapists for a diverse range of therapies. RTG Products are distributed in Acute, Sub Acute, Skilled Nursing, Home and Hospice Settings, through our increasing network of distribution partners.


News Articles [1942 Associated News Articles listed on BioPortfolio]

Melinta Therapeutics and Menarini Group Enter Commercial Agreement

Melinta Therapeutics (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, and Menarini Group, an Italian bioph...

Roivant launches biopharmaceutical firm to develop therapeutics for respiratory diseases

Respivant will be led by chief executive officer Bill Gerhart, Executive Vice President for Clinical and Regulatory Ahmet Tutuncu, MD, PhD, and Executive Vice President for Development and The post R...

IP Group: Avacta Signs Development Alliance With LG Chem Worth Up To $310 Mln

LONDON (dpa-AFX) - IP Group plc (IPO.L) , a developer of intellectual property-based businesses, announced Monday that portfolio company Avacta Group plc has agreed an Affimer therapeutics develop...

Avacta Group PLC signs first significant pharmaceutical licensing deal

Alastair Smith, chief executive of Avacta Group PLC (LON:AVCT), discusses with Proactive London an Affimer therapeutics development partnership and license agreement that's been signed with LG Chem ...

SMi Group announces the 10th Annual RNA Therapeutics Conference

20 - 21 February 2019, London, UK. Undoubtedly, the field of RNA therapeutics is currently undergoing a major expansion, and the potential for using RNA drugs for personalised medicines and immunother...

Your NEJM Group Today: M. pneumoniae–Associated Mucositis / Physician Burnout / New Mexico Gastro. Opportunities

See what's happening around NEJM Group: NEJM Primary Care/Hospitalist Page: Images in clinical medicine: A 26-year-old man presented with symptoms of respiratory...

Pulmonologists call for speedy respiratory drug development and approval process

With the increasing burden of respiratory diseases globally and particularly in India, and the burgeoning costs of inhaled medications that are projected to run into billions of dollars, pulmonology a...

Middle East respiratory syndrome

Middle East respiratory syndrome (MERS) is an acute viral respiratory tract infection caused by the novel betacoronavirus. Cases have been limited to the Arabian Peninsula and its surrounding countr...

PubMed Articles [3542 Associated PubMed Articles listed on BioPortfolio]

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

ABO histo-blood group and risk of respiratory atopy in children: a review of published evidence.

Besides their fundamental role in transfusion medicine, ABO and other histo-blood group antigens are associated with the pathogenesis of some human diseases such as malignancy and thrombosis. Reports ...

Analysis of genetic variability of respiratory syncytial virus groups A and B in Kuwait.

Respiratory syncytial virus (RSV) is the most frequently identified viral agent in infants, children, and elderly people with acute respiratory tract infections (ARTIs). This study is the only one of ...

Community acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality from pulmonary virus-bacterial mixed infections.

Risk factors (RFs) and mortality data of community acquire respiratory virus (CARVs) lower respiratory tract disease (LRTD) with concurrent pulmonary co-infections in the setting of allogeneic hematop...

FUT2 Genetic Variants and Reported Respiratory and Gastrointestinal Illnesses During Infancy.

Fucosyltransferase 2 (FUT2) controls the production of digestive and respiratory epithelia of histo-blood group antigens involved in the attachment of pathogens. The aim of our study was to relate FUT...

Clinical Trials [6642 Associated Clinical Trials listed on BioPortfolio]

Effectiveness of Respiratory Physiotherapy in Children With Neuromuscular Disease

The main objective of this study is to determine whether the Respiratory Physiotherapy allows improvement or maintenance of respiratory function in children with Neuromuscular Diseases, ag...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Delivery Room Management Trial of Premature Infants at High Risk of Respiratory Distress Syndrome

The best mode of delivery room stabilization for premature infants at high risk for respiratory distress syndrome is unknown. The protocol evaluates the impact of three distinct methods of...

SLI MANEUVER and RESPIRATORY MORBIDITIES

Purpose: The investigators hypothesis is that, as compared to the only nCPAP-applied group, application of SLI maneuver followed by respiratory support with nCPAP immediately afterwards in...

Companies [3215 Associated Companies listed on BioPortfolio]

Respiratory Therapeutics Group

RTG is a global manufacturer of Respiratory Devices, with an extensive brand portfolio of respiratory disposable devices, products and service solutions designed by Respira...

Therabron Therapeutics, Inc.

Therabron Therapeutics, Inc. is a clinical-stage biotechnology company, founded in 2007 and located in Rockville, MD. Therabron is focused on the advancement of respiratory therap...

Pearl Therapeutics Inc.

Pearl Therapeutics is developing combination therapies for the treatment of highly prevalent respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma. Leveraging its pro...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Respira Therapeutics

Respira Therapeutics is an early-stage product development company focused on pulmonary delivery of therapeutics for respiratory diseases with unmet medical needs. The company rea...

More Information about "Respiratory Therapeutics Group" on BioPortfolio

We have published hundreds of Respiratory Therapeutics Group news stories on BioPortfolio along with dozens of Respiratory Therapeutics Group Clinical Trials and PubMed Articles about Respiratory Therapeutics Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Respiratory Therapeutics Group Companies in our database. You can also find out about relevant Respiratory Therapeutics Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...


Corporate Database Quicklinks



Searches Linking to this Company Record